1. Wright A.D., Hill D.M., Lowy C., Fraser T.R. Mortality in acromegaly. Q. J. Med. 1970, 39: 1–16.
2. Bates A.S., Van’t Hoff W., Jones J.M., Clayton R.N. An audit of outcome of treatment in acromegaly. Q. J. Med. 1993, 86: 293–299.
3. Rajasoorya C., Holdaway I.M., Wrightson P., Scott D.J., Ibbertson H.K. Determinants of clinical outcome and survival in acromegaly. Clin. Endocrinol. (Oxf.) 1994, 41: 95–102.
4. Ezzat S., Snyder P.J., Young W.F., Boyajy L.D., Newman C., Klibanski A., Molitch M.E., Boyd A.E., Sheeler L., Cook D.M., Malarkey W.B., Jackson I., Vance M.L., Thorner M.O., Barkan A., Frohman L.A., Melmed S. Octreotide treatment of acromegaly: a randomized multicenter study. Ann. Intern. Med. 1992, 117: 711–718.
5. Melmed S., Jackson I., Kleinberg D., Klibanski A. Current treatment guidelines for acromegaly. J. Clin. Endocrinol. Metab. 1998, 83: 2646–2652.